Complementary and alternative medicine use among ischemic stroke survivors in Jeddah, Saudi Arabia

References

1. ↵
   1. Murray CJ,
   2. Vos T,
   3. Lozano R,
   4. Naghavi M,
   5. Flaxman AD,
   6. Michaud C,
   7. et al.

   (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197–2223.
2. ↵
   1. Béjot Y,
   2. Delpont B,
   3. Giroud M

   (2016) Rising Stroke Incidence in Young Adults: More Epidemiological Evidence, More Questions to Be Answered. J Am Heart Assoc 5, e003661.
3. ↵
   1. Benjamin EJ,
   2. Blaha MJ,
   3. Chiuve SE,
   4. Cushman M,
   5. Das SR,
   6. Deo R,
   7. et al.

   (2017) American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135, e146–e603.
4. ↵
   1. Gorelick PB

   (2019) The global burden of stroke: persistent and disabling. Lancet Neurol 18, 417–418.
5. ↵
   1. Feigin VL,
   2. Norrving B,
   3. George MG,
   4. Foltz JL,
   5. Roth GA,
   6. Mensah GA

   (2016) Prevention of stroke: a strategic global imperative. Nat Rev Neurol 12, 501–12.
6. ↵
   1. Feigin VL,
   2. Nguyen G,
   3. Cercy K,
   4. Johnson CO,
   5. Alam T,
   6. Parmar PG,
   7. et al.

   (2018) GBD 2016 Lifetime Risk of Stroke Collaborators. GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med 379, 2429–2437.
7. ↵
   1. Pandian JD,
   2. Toor G,
   3. Arora R,
   4. Kaur P,
   5. Dheeraj KV,
   6. Bhullar RS,
   7. et al.

   (2012) Complementary and alternative medicine treatments among stroke patients in India. Top Stroke Rehabil 19, 384–394.
8. ↵
   1. Pandian JD,
   2. Toor G,
   3. Arora R,
   4. Kaur P,
   5. Dheeraj KV,
   6. Bhullar RS,
   7. et al.

   (2012) Complementary and alternative medicine treatments among stroke patients in India. Top Stroke Rehabil 19, 384–394.
9. ↵
   1. Mohammad Y,
   2. Al-Ahmari A,
   3. Al-Dashash F,
   4. Al-Hussain F,
   5. Al-Masnour F,
   6. Masoud A,
   7. et al.

   (2015) Pattern of traditional medicine use by adult Saudi patients with neurological disorders. BMC Complement Altern Med 15, 102.
10. ↵
    1. Posadzki P,
    2. Watson LK,
    3. Alotaibi A,
    4. Ernst E

    (2013) Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med (Lond) 13, 126–131.
11. ↵
    1. Salem EM,
    2. Yar T,
    3. Bamosa AO,
    4. Al-Quorain A,
    5. Yasawy MI,
    6. Alsulaiman RM,
    7. et al.

    (2010) Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol 16, 207–214.
12. ↵
    1. Prasad K,
    2. Sharma V,
    3. Lackore K,
    4. Jenkins SM,
    5. Prasad A,
    6. Sood A

    (2013) Use of complementary therapies in cardiovascular disease. Am J Cardiol 111, 339–345.
13. ↵
    1. Thomson P,
    2. Jones J,
    3. Evans JM,
    4. Leslie SL

    (2012) Factors influencing the use of complementary and alternative medicine and whether patients inform their primary care physician. Complement Ther Med 20, 45–53.
14. ↵
    1. Saibul N,
    2. Shariff ZM,
    3. Rahmat A,
    4. Sulaiman S,
    5. Yaw YH

    (2012) Use of complementary and alternative medicine among breast cancer survivors. Asian Pac J Cancer Prev 13, 4081–4086.
15. ↵
    1. Nazik E,
    2. Nazik H,
    3. Api M,
    4. Kale A,
    5. Aksu M

    (2012) Complementary and alternative medicine use by gynecologic oncology patients in Turkey. Asian Pac J Cancer Prev 13, 21–25.
16. ↵
    1. Jan MM,
    2. Basamh MS,
    3. Bahassan OM,
    4. Jamal-Allail AA

    (2009) The use of complementary and alternative therapies in Western Saudi Arabia. Saudi Med J 30, 682–686.
17. ↵
    1. Hunt KJ,
    2. Coelho HF,
    3. Wider B,
    4. Perry R,
    5. Hung SK,
    6. Terry R,
    7. et al.

    (2010) Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract 64, 1496–1502.
18. ↵
    1. Jonas WB,
    2. Eisenberg D,
    3. Hufford D,
    4. Crawford C

    (2013) The evolution of complementary and alternative medicine (CAM) in the USA over the last 20 years. Forsch Komplement Med 20, 65–72.
19. ↵
    1. Wiesener S,
    2. Falkenberg T,
    3. Hegyi G,
    4. Hök J,
    5. Roberti di Sarsina P,
    6. Fønnebø V

    (2012) Legal status and regulation of complementary and alternative medicine in Europe. Forsch Komplement Med 19, 29–36.
20. ↵
    1. Thirthalli J,
    2. Zhou L,
    3. Kumar K,
    4. Gao J,
    5. Vaid H,
    6. Liu H,
    7. et al.

    (2016) Traditional, complementary, and alternative medicine approaches to mental health care and psychological wellbeing in India and China. Lancet Psychiatry 3, 660–672.
21. ↵
    1. Cui Y,
    2. Shu XO,
    3. Gao Y,
    4. Wen W,
    5. Ruan ZX,
    6. Jin F,
    7. et al.

    (2004) Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat 85, 263–270.
22. ↵
    1. Chen FP,
    2. Kung YY,
    3. Chen TJ,
    4. Hwang SJ

    (2006) Demographics and patterns of acupuncture use in the Chinese population: the Taiwan experience. J Altern Complement Med 12, 379–387.
23. ↵
    1. Wong VC

    (2009) Use of complementary and alternative medicine (CAM) in autism spectrum disorder (ASD): comparison of Chinese and western culture (Part A). J Autism Dev Disord 39, 454–463.
24. ↵
    1. Alqahtani MM

    (2015) Understanding the sociocultural health belief model influencing health behaviors among Saudi stroke survivors. Neurosci Med 6, 149.
25. ↵
    1. AlBedah A,
    2. Khalil M,
    3. Elolemy A,
    4. Elsubai I,
    5. Khalil A

    (2011) Hijama (cupping): a review of the evidence. Focus Altern Complement Ther 16, 12–16.
26. ↵
    1. El Sayed SM,
    2. Al-quliti AS,
    3. Mahmoud HS,
    4. Baghdadi H,
    5. Maria RA,
    6. Nabo MM,
    7. et al.

    (2014) Therapeutic benefits of Al-hijamah: in light of modern medicine and prophetic medicine. American Journal of Medical and Biological Research 2, 46–71.
27. ↵
    1. Al-Faris EA

    (2000) The pattern of alternative medicine use among patients attending health centres in a military community in riyadh. J Family Community Med 7, 17–25.
28. ↵
    1. Taylor DM,
    2. Walsham N,
    3. Taylor SE,
    4. Wong L

    (2006) Potential interactions between prescription drugs and complementary and alternative medicines among patients in the emergency department. Pharmacotherapy 26, 634–640.
29. ↵
    1. Abou-Elhamd KE

    (2009) Kaiy as traditional therapy for pain: is it helpful or a myth? J Laryngol Otol 123, 566–568.
30. ↵
    1. Bogusz MJ,
    2. al Tufail M,
    3. Hassan H

    (2002) How natural are ‘natural herbal remedies’? A Saudi perspective. Adverse Drug React Toxicol Rev 21, 219–229.
31. ↵
    1. Yussman SM,
    2. Ryan SA,
    3. Auinger P,
    4. Weitzman M

    (2004) Visits to complementary and alternative medicine providers by children and adolescents in the United States. Ambul Pediatr 4, 429–435.
32. ↵
    1. Wells RE,
    2. Phillips RS,
    3. Schachter SC,
    4. McCarthy EP

    (2010) Complementary and alternative medicine use among US adults with common neurological conditions. J Neurol 257, 1822–1831.
33. ↵
    1. Shah SH,
    2. Engelhardt R,
    3. Ovbiagele B

    (2008) Patterns of complementary and alternative medicine use among United States stroke survivors. J Neurol Sci 271, 180–185.
34. ↵
    1. Shin YI,
    2. Yang CY,
    3. Joo MC,
    4. Lee SG,
    5. Kim JH,
    6. Lee MS

    (2008) Patterns of using complementary and alternative medicine by stroke patients at two university hospitals in Korea. Evid Based Complement Alternat Med 5, 231–235.
35. ↵
    1. Kadir AA,
    2. Hamid AH,
    3. Mohammad M

    (2015) Pattern of complementary and alternative medicine use among Malaysian stroke survivors: A hospital-based prospective study. J Tradit Complement Med 5, 157–160.
36. ↵
    1. Patterson C,
    2. Arthur H

    (2009) A complementary alternative medicine questionnaire for young adults. Integrative medicine insights, 4, IMI-S2281.
37. ↵
    1. Ali MF,
    2. Abdul Aziz AF,
    3. Rashid MR,
    4. Che Man Z,
    5. Amir AA,
    6. Lim YS,
    7. et al.

    (2015) Usage of Traditional and Complementary Medicine (T & CM): Prevalence, Practice and Perception among Post Stroke Patients Attending Conventional Stroke Rehabilitation in A Teaching Hospital in Malaysia. Med J Malaysia 70, 18–23.
38. ↵
    1. Al Moamary MS

    (2008) Unconventional therapy use among asthma patients in a tertiary care center in Riyadh, Saudi Arabia. Ann Thorac Med 3, 48–51.
39. ↵
    1. Al-Saeedi M,
    2. Elzubier AG,
    3. Bahnassi AA,
    4. Al-Dawood KM

    (2003) Patterns of belief and use of traditional remedies by diabetic patients in Mecca, Saudi Arabia. East Mediterr Health J 9, 99–107.
40. ↵
    1. Sait KH,
    2. Anfinan NM,
    3. Eldeek B,
    4. Al-Ahmadi J,
    5. Al-Attas M,
    6. Sait HK,
    7. et al.

    (2014) Perception of patients with cancer towards support management services and use of complementary alternative medicine—a single institution hospital-based study in Saudi Arabia. Asian Pac J Cancer Prev 15, 2547–2554.
41. ↵
    1. Alrowais NA,
    2. Alyousefi NA

    (2017) The prevalence extent of Complementary and Alternative Medicine (CAM) use among Saudis. Saudi Pharm J 25, 306–318.
42. ↵
    1. Elolemy AT,
    2. Albedah AM

    (2012) Public knowledge, attitude and practice of complementary and alternative medicine in riyadh region, saudi arabia. Oman Med J 27, 20–26.
43. ↵
    1. Brown W,
    2. Bauman A,
    3. Chey T,
    4. Trost S,
    5. Mummery K

    (2004) Comparison of surveys used to measure physical activity. Aust N Z J Public Health 28, 128–134.
44. ↵
    1. Mummery WK,
    2. Schofield G,
    3. Spence JC

    (2002) The epidemiology of medically attended sport and recreational injuries in Queensland. J Sci Med Sport 5, 307–320.